namita thapar to gain ₹127.8 cr from emcure pharma ipo
Published 1 month ago • 1.5K plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
1:14
namita thapar-backed emcure pharma ipo to fetch her 127 cr on exit
-
0:43
namita thapar's emcure pharma makes bumper #stockmarket debut, lists at 31% premium on nse
-
2:26
‘shark’ namita thapar’s investment swells 38,200% after strong emcure pharma listing! | details
-
0:48
namita thapar's emcure pharma ipo opens: should you bid? | ipo #shorts
-
8:15
emcure pharmaceuticals share news | emcure pharmaceuticals share price today | stock market tak
-
10:21
pharma sector will be in favour with blockbuster products in the pipeline: icici pru amc | cnbc tv18
-
6:16
akums drugs to launch ipo worth ₹1,856 cr | management on growth & capex roadmap | et now
-
3:00
emcure pharma ipo launches today; everything you need to know about the pharma company
-
6:46
emcure pharma ipo lists at 30% premium | namita thapar & satish mehta share details | business news
-
0:50
#sharktankindia fame namita thapar's emcure pharma lists at 31% premium on nse | new listing
-
39:25
live: namita thapar-backed emcure pharma ipo to debut on the bourses | ipo listing | n18l |cnbc tv18
-
4:17
emcure pharmaceuticals ipo review | issue details, financials, products | namita thapar | must watch
-
19:30
will you invest in shark tank's namita thapar's company. emcure pharma ipo to open on july 3rd
-
4:34
top 10 things to know about emcure pharmaceuticals ipo | namita thapar's emcure pharma ipo review
-
2:19
emcure pharma makes a stellar debut, lists at 31% premium to issue price | cnbc tv18
-
25:46
namita thapar-backed emcure pharma’s rs 1,952 cr ipo opens|management on post-ipo roadmap| ipo watch
-
0:53
emcure pharma ipo listing: shares debut at nearly 32% premium over ipo price | n18s | cnbc tv18
-
5:08
emcure pharma ipo: namita thappar on tie up with sanofi & in-house products for cardiac segment
-
16:05
emcure pharma ipo summary | ca rachana ranade
-
5:44
emcure pharma ipo launch: what to expect? market expert sneha poddar analysis the ipo debut
-
4:28
young leaders program 2024 i in conversation with namita thapar ed, emcure pharmaceuticals
-
3:07
namita thapar’s ipo | emcure pharma ipoவை வாங்கலாமா? | oneindia tamil